BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ge X, Yamaguchi Y, Zhao L, Bury L, Gresele P, Berube C, Leung LL, Morser J. Prochemerin cleavage by factor XIa links coagulation and inflammation. Blood 2018;131:353-64. [PMID: 29158361 DOI: 10.1182/blood-2017-07-792580] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Zhao L, Yamaguchi Y, Shen WJ, Morser J, Leung LLK. Dynamic and tissue-specific proteolytic processing of chemerin in obese mice. PLoS One 2018;13:e0202780. [PMID: 30161155 DOI: 10.1371/journal.pone.0202780] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
2 Heal SL, Hardy LJ, Wilson CL, Ali M, Ariëns RAS, Foster R, Philippou H. Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12715] [Reference Citation Analysis]
3 Wenzel P. Monocytes as immune targets in arterial hypertension. Br J Pharmacol 2019;176:1966-77. [PMID: 29885051 DOI: 10.1111/bph.14389] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
4 Buechler C, Feder S, Haberl EM, Aslanidis C. Chemerin Isoforms and Activity in Obesity. Int J Mol Sci 2019;20:E1128. [PMID: 30841637 DOI: 10.3390/ijms20051128] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 12.3] [Reference Citation Analysis]
5 Maroney SA, Peterson JA, Zwifelhofer W, Martinez ND, Yan K, Bercovitz RS, Woods RK, Mast AE. Plasma Proteolytic Cascade Activation during Neonatal Cardiopulmonary Bypass Surgery. Thromb Haemost 2018;118:1545-55. [PMID: 30086574 DOI: 10.1055/s-0038-1667198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Bravo MC, Tejiram S, McLawhorn MM, Moffatt LT, Orfeo T, Jett-Tilton M, Pusateri AE, Shupp JW, Brummel-Ziedins KE. Utilizing Plasma Composition Data to Help Determine Procoagulant Dynamics in Patients with Thermal Injury: A Computational Assessment. Mil Med 2019;184:392-9. [PMID: 30901410 DOI: 10.1093/milmed/usy397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhao L, Yamaguchi Y, Ge X, Robinson WH, Morser J, Leung LLK. Chemerin 156F, generated by chymase cleavage of prochemerin, is elevated in joint fluids of arthritis patients. Arthritis Res Ther 2018;20:132. [PMID: 29973268 DOI: 10.1186/s13075-018-1615-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
8 Zhang Y, Shen WJ, Qiu S, Yang P, Dempsey G, Zhao L, Zhou Q, Hao X, Dong D, Stahl A, Kraemer FB, Leung LL, Morser J. Chemerin regulates formation and function of brown adipose tissue: Ablation results in increased insulin resistance with high fat challenge and aging. FASEB J 2021;35:e21687. [PMID: 34089273 DOI: 10.1096/fj.202100156R] [Reference Citation Analysis]
9 Fischer TF, Beck-Sickinger AG. Chemerin - exploring a versatile adipokine. Biol Chem 2022. [PMID: 35040613 DOI: 10.1515/hsz-2021-0409] [Reference Citation Analysis]
10 Sotiropoulos GP, Dalamaga M, Antonakos G, Marinou I, Vogiatzakis E, Kotopouli M, Karampela I, Christodoulatos GS, Lekka A, Papavassiliou AG. Chemerin as a biomarker at the intersection of inflammation, chemotaxis, coagulation, fibrinolysis and metabolism in resectable non-small cell lung cancer. Lung Cancer 2018;125:291-9. [PMID: 30429035 DOI: 10.1016/j.lungcan.2018.10.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
11 Chou HH, Teng MS, Hsu LA, Er LK, Wu S, Ko YL. Circulating chemerin level is associated with metabolic, biochemical and haematological parameters-A population-based study. Clin Endocrinol (Oxf) 2021;94:927-39. [PMID: 33576089 DOI: 10.1111/cen.14441] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Ferland DJ, Mullick AE, Watts SW. Chemerin as a Driver of Hypertension: A Consideration. Am J Hypertens 2020;33:975-86. [PMID: 32453820 DOI: 10.1093/ajh/hpaa084] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
13 Lyu M, Zhou Z, Wang X, Lv H, Wang M, Pan G, Wang Y, Fan G, Gao X, Feng Y, Zhu Y. Network Pharmacology-Guided Development of a Novel Integrative Regimen to Prevent Acute Graft-vs.-Host Disease. Front Pharmacol 2018;9:1440. [PMID: 30618740 DOI: 10.3389/fphar.2018.01440] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
14 Hsu LA, Chou HH, Teng MS, Wu S, Ko YL. Circulating chemerin levels are determined through circulating platelet counts in nondiabetic Taiwanese people: A bidirectional Mendelian randomization study. Atherosclerosis 2021;320:61-9. [PMID: 33545615 DOI: 10.1016/j.atherosclerosis.2021.01.014] [Cited by in F6Publishing: 1] [Reference Citation Analysis]